Logo image of AQB

AQUABOUNTY TECHNOLOGIES (AQB) Stock Price, Quote, News and Overview

NASDAQ:AQB - Nasdaq - US03842K3095 - Common Stock - Currency: USD

0.6778  +0.02 (+2.7%)

After market: 0.6528 -0.02 (-3.69%)

AQB Quote, Performance and Key Statistics

AQUABOUNTY TECHNOLOGIES

NASDAQ:AQB (3/7/2025, 8:05:20 PM)

After market: 0.6528 -0.02 (-3.69%)

0.6778

+0.02 (+2.7%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High2.31
52 Week Low0.47
Market Cap2.62M
Shares3.87M
Float3.79M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)03-31 2025-03-31/amc
IPO01-09 2017-01-09


AQB short term performance overview.The bars show the price performance of AQB in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

AQB long term performance overview.The bars show the price performance of AQB in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of AQB is 0.6778 USD. In the past month the price decreased by -9.63%. In the past year, price decreased by -69.05%.

AQUABOUNTY TECHNOLOGIES / AQB Daily stock chart

AQB Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 21.17 378.30B
AMGN AMGEN INC 16.39 174.51B
GILD GILEAD SCIENCES INC 25.47 146.22B
VRTX VERTEX PHARMACEUTICALS INC 1683.76 125.39B
REGN REGENERON PHARMACEUTICALS 15.5 77.34B
ARGX ARGENX SE - ADR 231.21 36.10B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 31.66B
ONC BEIGENE LTD-ADR N/A 26.47B
BNTX BIONTECH SE-ADR N/A 26.08B
BIIB BIOGEN INC 9.13 22.01B
NTRA NATERA INC N/A 19.02B
GMAB GENMAB A/S -SP ADR 24.89 15.34B

About AQB

Company Profile

AQB logo image AquaBounty Technologies, Inc. engages in the provision of land-based aquaculture services. The company is headquartered in Harvard, Massachusetts and currently employs 104 full-time employees. The company went IPO on 2017-01-09. The firm provides fresh Atlantic salmon to nearby markets by raising its fish in monitored land-based fish farms. Its land-based Recirculating Aquaculture System (RAS) farms, including a grow-out farm located in Indiana, United States and a broodstock and egg production farm located on Prince Edward Island, Canada, are designed to prevent disease and to include multiple levels of fish containment to protect wild fish populations. RAS facilities provide water treatment technology, including the use of ozone, salt treatment and ultraviolet radiation to kill potential bacterial, fungal, or viral pathogens which might enter the system. The firm is vertically integrated and maintains its own broodstock hatchery, which produces the eggs that it grow-out to harvest size in its production farms. The firm has expertise in fish breeding, genetics, and health and nutrition to deliver disruptive solutions.

Company Info

AQUABOUNTY TECHNOLOGIES

233 Ayer Road Suite 4, Suite 4

Harvard MASSACHUSETTS 01754 US

CEO: Sylvia A. Wulf

Employees: 104

Company Website: https://aquabounty.com/

Investor Relations: https://investors.aquabounty.com/

Phone: 19786486000

AQUABOUNTY TECHNOLOGIES / AQB FAQ

What is the stock price of AQUABOUNTY TECHNOLOGIES today?

The current stock price of AQB is 0.6778 USD. The price increased by 2.7% in the last trading session.


What is the ticker symbol for AQUABOUNTY TECHNOLOGIES stock?

The exchange symbol of AQUABOUNTY TECHNOLOGIES is AQB and it is listed on the Nasdaq exchange.


On which exchange is AQB stock listed?

AQB stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for AQUABOUNTY TECHNOLOGIES stock?

8 analysts have analysed AQB and the average price target is 1.02 USD. This implies a price increase of 50.49% is expected in the next year compared to the current price of 0.6778. Check the AQUABOUNTY TECHNOLOGIES stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is AQUABOUNTY TECHNOLOGIES worth?

AQUABOUNTY TECHNOLOGIES (AQB) has a market capitalization of 2.62M USD. This makes AQB a Nano Cap stock.


How many employees does AQUABOUNTY TECHNOLOGIES have?

AQUABOUNTY TECHNOLOGIES (AQB) currently has 104 employees.


What are the support and resistance levels for AQUABOUNTY TECHNOLOGIES (AQB) stock?

AQUABOUNTY TECHNOLOGIES (AQB) has a support level at 0.67 and a resistance level at 0.68. Check the full technical report for a detailed analysis of AQB support and resistance levels.


Is AQUABOUNTY TECHNOLOGIES (AQB) expected to grow?

The Revenue of AQUABOUNTY TECHNOLOGIES (AQB) is expected to decline by -65.64% in the next year. Check the estimates tab for more information on the AQB EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy AQUABOUNTY TECHNOLOGIES (AQB) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does AQUABOUNTY TECHNOLOGIES (AQB) stock pay dividends?

AQB does not pay a dividend.


When does AQUABOUNTY TECHNOLOGIES (AQB) report earnings?

AQUABOUNTY TECHNOLOGIES (AQB) will report earnings on 2025-03-31, after the market close.


What is the Price/Earnings (PE) ratio of AQUABOUNTY TECHNOLOGIES (AQB)?

AQUABOUNTY TECHNOLOGIES (AQB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-7.54).


What is the Short Interest ratio of AQUABOUNTY TECHNOLOGIES (AQB) stock?

The outstanding short interest for AQUABOUNTY TECHNOLOGIES (AQB) is 3.98% of its float. Check the ownership tab for more information on the AQB short interest.


AQB Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to AQB. When comparing the yearly performance of all stocks, AQB is a bad performer in the overall market: 93.54% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

AQB Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to AQB. AQB may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AQB Financial Highlights

Over the last trailing twelve months AQB reported a non-GAAP Earnings per Share(EPS) of -7.54. The EPS decreased by -10.88% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -62.4%
ROE -73.45%
Debt/Equity 0.05
Chartmill High Growth Momentum
EPS Q2Q%45%
Sales Q2Q%-93.59%
EPS 1Y (TTM)-10.88%
Revenue 1Y (TTM)-46.96%

AQB Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 45% to AQB. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of -136.44% and a revenue growth -65.64% for AQB


Ownership
Inst Owners12.78%
Ins Owners1.86%
Short Float %3.98%
Short Ratio0.26
Analysts
Analysts45
Price Target1.02 (50.49%)
EPS Next Y-136.44%
Revenue Next Year-65.64%